Maravai LifeSciences Holdings Inc (MRVI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.51 is considered Undervalued compared with the five-year average of 1201.33. The fair price of Maravai LifeSciences Holdings Inc (MRVI) is between 13.20 to 16.99 according to relative valuation method. Compared to the current price of 3.61 USD , Maravai LifeSciences Holdings Inc By Undervalued By 72.65%.

Relative Value

Fair Zone

13.20-16.99

Current Price：3.61

72.65%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Maravai LifeSciences Holdings Inc (MRVI) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Maravai LifeSciences Holdings Inc (MRVI) has a current Price-to-Book (P/B) ratio of 2.00. Compared to its 3-year average P/B ratio of 2.21, the current P/B ratio is approximately -9.45% higher. Relative to its 5-year average P/B ratio of 8.13, the current P/B ratio is about -75.35% higher. Maravai LifeSciences Holdings Inc (MRVI) has a Forward Free Cash Flow (FCF) yield of approximately -13.45%. Compared to its 3-year average FCF yield of 3.33%, the current FCF yield is approximately -504.52% lower. Relative to its 5-year average FCF yield of 6.85%, the current FCF yield is about -296.41% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MRVI competitors is 30.87, providing a benchmark for relative valuation. Maravai LifeSciences Holdings Inc Corp (MRVI.O) exhibits a P/S ratio of 2.51, which is -91.87% above the industry average. Given its robust revenue growth of -11.59%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MRVI increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MRVI in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MRVI currently overvalued or undervalued?

Maravai LifeSciences Holdings Inc (MRVI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.51 is considered Undervalued compared with the five-year average of 1201.33. The fair price of Maravai LifeSciences Holdings Inc (MRVI) is between 13.20 to 16.99 according to relative valuation method. Compared to the current price of 3.61 USD, Maravai LifeSciences Holdings Inc is Undervalued By 72.65%.

What is Maravai LifeSciences Holdings Inc (MRVI) fair value?

MRVI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Maravai LifeSciences Holdings Inc (MRVI) is between 13.20 to 16.99 according to relative valuation method.

How does MRVI's valuation metrics compare to the industry average?

The average P/S ratio for MRVI's competitors is 30.87, providing a benchmark for relative valuation. Maravai LifeSciences Holdings Inc Corp (MRVI) exhibits a P/S ratio of 2.51, which is -91.87% above the industry average. Given its robust revenue growth of -11.59%, this premium appears unsustainable.

What is the current P/B ratio for Maravai LifeSciences Holdings Inc (MRVI) as of Mar 03 2026?

As of Mar 03 2026, Maravai LifeSciences Holdings Inc (MRVI) has a P/B ratio of 2.00. This indicates that the market values MRVI at 2.00 times its book value.

What is the current FCF Yield for Maravai LifeSciences Holdings Inc (MRVI) as of Mar 03 2026?

As of Mar 03 2026, Maravai LifeSciences Holdings Inc (MRVI) has a FCF Yield of -13.45%. This means that for every dollar of Maravai LifeSciences Holdings Inc's market capitalization, the company generates -13.45 cents in free cash flow.

What is the current Forward P/E ratio for Maravai LifeSciences Holdings Inc (MRVI) as of Mar 03 2026?

As of Mar 03 2026, Maravai LifeSciences Holdings Inc (MRVI) has a Forward P/E ratio of -15.07. This means the market is willing to pay $-15.07 for every dollar of Maravai LifeSciences Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Maravai LifeSciences Holdings Inc (MRVI) as of Mar 03 2026?

As of Mar 03 2026, Maravai LifeSciences Holdings Inc (MRVI) has a Forward P/S ratio of 2.51. This means the market is valuing MRVI at $2.51 for every dollar of expected revenue over the next 12 months.

MRVI Valuation